Ignite Creation Date:
2024-05-06 @ 2:16 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04266197
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2020-01-22
Brief Title:
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study
Sponsor:
Respira Therapeutics Inc
Organization:
Respira Therapeutics Inc
Organization Data
Organization:
Respira Therapeutics Inc
Class:
INDUSTRY
Study ID:
RT234-PAH-CL202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Respira Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None